Industry
Drug Manufacturers - Specialty & Generic
Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as diabetes and complications of diabetes, fibrosis, infectious diseases, CNS diseases, oncology, pain and inflammation, immunology, rare diseases, respiratory diseases, and women's health. It has collaboration agreements with Bayer AG; Lilly; Chinook Therapeutics; Novo Nordisk A/S; Galapagos; Pfizer Inc.; CONBA Pharmaceutical Co., Ltd.; Bristol Myers Squibb Company; Zhejiang JingXin Pharmaceutical Co., Ltd; Kazia Therapeutics; Apeiron Biologics; and Takeda Pharmaceuticals. The company was formerly known as Evotec AG and changed its name to Evotec SE in April 2019. Evotec SE was incorporated in 1993 and is headquartered in Hamburg, Germany.
Loading...
Open
4.59
Mkt cap
1.6B
Volume
123K
High
4.59
P/E Ratio
-8.98
52-wk high
12.00
Low
4.38
Div yield
N/A
52-wk low
2.85
Portfolio Pulse from
November 29, 2024 | 7:15 am
Portfolio Pulse from
November 22, 2024 | 4:30 pm
Portfolio Pulse from
November 22, 2024 | 2:15 pm
Portfolio Pulse from
November 14, 2024 | 9:30 pm
Portfolio Pulse from
November 07, 2024 | 12:30 am
Portfolio Pulse from
November 06, 2024 | 6:45 am
Portfolio Pulse from Benzinga Insights
October 23, 2024 | 8:31 pm
Portfolio Pulse from Nabaparna Bhattacharya
October 23, 2024 | 2:29 pm
Portfolio Pulse from Benzinga Newsdesk
October 23, 2024 | 12:07 pm
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.